NeoPharm Co Ltd
KOSDAQ:092730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NeoPharm Co Ltd
Net Change in Cash
NeoPharm Co Ltd
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Net Change in Cash
₩8.6B
|
CAGR 3-Years
31%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
AmorePacific Corp
KRX:090430
|
Net Change in Cash
₩73B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-14%
|
|
|
Amorepacific Group
KRX:002790
|
Net Change in Cash
₩32.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Cosmax Inc
KRX:192820
|
Net Change in Cash
-₩64.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Net Change in Cash
-₩167.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Net Change in Cash
₩83.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's Net Change in Cash?
Net Change in Cash
8.6B
KRW
Based on the financial report for Dec 31, 2025, NeoPharm Co Ltd's Net Change in Cash amounts to 8.6B KRW.
What is NeoPharm Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
20%
Over the last year, the Net Change in Cash growth was 35%. The average annual Net Change in Cash growth rates for NeoPharm Co Ltd have been 31% over the past three years , 9% over the past five years , and 20% over the past ten years .
